Diversity in Clinical Pharmacology: A Call to Action

被引：4

作者：

Brown, Karen ^{[1
]}

Etrouth, Shravani ^{[2
]}

Jayachandran, Priya ^{[3
]}

Moore, Jason ^{[4
]}

Oni-Orisan, Akinyemi ^{[5
]}

Vasist, Lakshmi ^{[6
]}

Zheng, Songmao ^{[7
]}

Zhou, Zhu ^{[8
]}

Dresser, Mark ^{[5
,9
]}

机构：

[1] Univ Montana, Missoula, MT USA

[2] Jawaharlal Nehru Technol Univ, Hyderabad, India

[3] Pfizer Inc, Cambridge, MA USA

[4] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Silver Spring, MD USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] GlaxoSmithKline, Chapel Hill, NC USA

[7] Adagene Inc, San Diego, CA USA

[8] CUNY York Coll, Jamaica, NY USA

[9] Gilead Sci Inc, Foster City, CA 94404 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷 / 03期

关键词：

D O I：

10.1002/cpt.2852

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Prioritization of diversity, equity, and inclusion in all facets of our work is long overdue for the clinical pharmacology community. Increasing diversity in clinical research will deepen our understanding of nuanced patient populations and help improve all patient outcomes. Fostering an inclusive and diverse workforce will lead to broader perspectives that can better inform critical decisions and create work environments where everyone can thrive. In this call to action, we invite you to join us.

引用

页码：483 / 485

页数：3

共 50 条

[31] Diversity and Inclusion in Libraries: A Call to Action And Strategies for Success
Moore, Jon
TECHNICAL SERVICES QUARTERLY, 2020, 37 (03) : 350 - 351
[32] Bisphosphonates: Pharmacology, Mechanisms of Action and Clinical Uses
R. G. G. Russell
P. I. Croucher
M. J. Rogers
Osteoporosis International, 1999, 9 : S66 - S80
[33] THE CLINICAL-PHARMACOLOGY OF THE ANTIHYPERTENSIVE ACTION OF GUANFACINE
SAFAR, M
WEISS, Y
GEORGES, D
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1980, 73 (10): : 1171 - 1177
[34] Bisphosphonates: Pharmacology, mechanisms of action and clinical uses
Russell, RGG
Croucher, PI
Rogers, MJ
OSTEOPOROSIS INTERNATIONAL, 1999, 9 (Suppl 2) : 66 - 80
[35] CLINICAL-PHARMACOLOGY OF MULTIPLE ACTION COMPOUNDS
PRICHARD, BNC
TOMLINSON, B
ZEITSCHRIFT FUR KARDIOLOGIE, 1989, 78 : 1 - 6
[36] A call to action: Patients' access to clinical trials
Sadler, GR
HEALTH & SOCIAL WORK, 2001, 26 (03) : 196 - 200
[37] Lack of transparency in clinical trials: a call for action
Ramirez, Jorge H.
COLOMBIA MEDICA, 2013, 44 (04): : 236 - 238
[38] Genetic counseling clinical supervision - A call to action
Reiser, Catherine
JOURNAL OF GENETIC COUNSELING, 2019, 28 (04) : 727 - 729
[39] A call to action: Patients' access to clinical trials
Sadler, GR
HEALTH & SOCIAL WORK, 2003, 28 (01) : 79 - 80
[40] Editorial: A Call to Action for an Antiracist Clinical Science
Galan, Chardee A.
Bekele, Beza
Boness, Cassandra
Bowdring, Molly
Call, Christine
Hails, Kate
McPhee, Jeanne
Mendes, Skyler Hawkins
Moses, Jacqueline
Northrup, Jessie
Rupert, Petra
Savell, Shannon
Sequeira, Stefanie
Tervo-Clemmens, Brenden
Tung, Irene
Vanwoerden, Salome
Womack, Sean
Yilmaz, Bilge
JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, 2021, 50 (01): : 12 - 57

← 1 2 3 4 5 →